ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $49,012,000 | +14.2% | 11,954,171 | -0.6% | 0.00% | 0.0% |
| Q4 2021 | $42,924,000 | -0.7% | 12,023,196 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $43,225,000 | -15.2% | 11,875,493 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $50,960,000 | +2.7% | 11,688,169 | -3.2% | 0.00% | 0.0% |
| Q1 2021 | $49,629,000 | +5.2% | 12,075,580 | +2.1% | 0.00% | -50.0% |
| Q4 2020 | $47,186,000 | +52.1% | 11,826,153 | +2.9% | 0.00% | +100.0% |
| Q3 2020 | $31,023,000 | -4.0% | 11,489,838 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $32,305,000 | +20.7% | 11,747,386 | +3.6% | 0.00% | 0.0% |
| Q1 2020 | $26,768,000 | -50.4% | 11,343,173 | -1.1% | 0.00% | -50.0% |
| Q4 2019 | $53,923,000 | +43.7% | 11,472,832 | +2.3% | 0.00% | 0.0% |
| Q3 2019 | $37,520,000 | +4.6% | 11,216,802 | +2.9% | 0.00% | 0.0% |
| Q2 2019 | $35,875,000 | +19.5% | 10,904,306 | +10.0% | 0.00% | +100.0% |
| Q1 2019 | $30,029,000 | +7.9% | 9,910,519 | -3.2% | 0.00% | 0.0% |
| Q4 2018 | $27,839,000 | -16.6% | 10,234,202 | +3.1% | 0.00% | 0.0% |
| Q3 2018 | $33,362,000 | +31.9% | 9,929,257 | +1.3% | 0.00% | 0.0% |
| Q2 2018 | $25,298,000 | +25.8% | 9,805,325 | +7.3% | 0.00% | 0.0% |
| Q1 2018 | $20,109,000 | +8.2% | 9,140,644 | -2.1% | 0.00% | 0.0% |
| Q4 2017 | $18,587,000 | -38.0% | 9,340,209 | +0.9% | 0.00% | -50.0% |
| Q3 2017 | $29,991,000 | +1.5% | 9,256,293 | +0.8% | 0.00% | 0.0% |
| Q2 2017 | $29,556,000 | +259.7% | 9,179,269 | +217.3% | 0.00% | – |
| Q1 2017 | $8,217,000 | +82070.0% | 2,893,239 | +26458.1% | 0.00% | – |
| Q1 2016 | $10,000 | +150.0% | 10,894 | +231.6% | 0.00% | – |
| Q4 2015 | $4,000 | -55.6% | 3,285 | -35.0% | 0.00% | – |
| Q3 2015 | $9,000 | -18.2% | 5,051 | 0.0% | 0.00% | – |
| Q2 2015 | $11,000 | -21.4% | 5,051 | 0.0% | 0.00% | – |
| Q1 2015 | $14,000 | +7.7% | 5,051 | 0.0% | 0.00% | – |
| Q4 2014 | $13,000 | +44.4% | 5,051 | 0.0% | 0.00% | – |
| Q3 2014 | $9,000 | -35.7% | 5,051 | 0.0% | 0.00% | – |
| Q2 2014 | $14,000 | -17.6% | 5,051 | +0.1% | 0.00% | – |
| Q1 2014 | $17,000 | -26.1% | 5,046 | 0.0% | 0.00% | – |
| Q4 2013 | $23,000 | +15.0% | 5,046 | 0.0% | 0.00% | – |
| Q3 2013 | $20,000 | -4.8% | 5,046 | 0.0% | 0.00% | – |
| Q2 2013 | $21,000 | – | 5,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|